Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

MEK inhibitors: a patent review 2008-2010

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Trujillo, John I

publication date

  • July 2011

journal

  • Expert Opinion on Therapeutic Patents  Journal

subject areas

  • Animals
  • Cell Differentiation
  • Drug Delivery Systems
  • Drug Design
  • Enzyme Inhibitors
  • Humans
  • Mitogen-Activated Protein Kinase Kinases
  • Neoplasms
  • Patents as Topic
  • Signal Transduction
scroll to property group menus

Research

keywords

  • ARRY-162 (ARRY-438162)
  • AS703026 (MSC1936369B)
  • AZD6244 (ARRY-142866)
  • AZD8330 (ARRY424704)
  • BAY869766 (RDEA119)
  • CI-1040
  • CI-1040/PD-184352
  • GSK1120212 (JTP-74057)
  • GSK2118436
  • MAPK
  • MEK
  • MEK inhibitor
  • MEK1
  • MEK2
  • PD-0325901
  • RO4987655 (CH4987655)
  • RO5068760
  • RO5126766
  • Ras/Raf/MEK/ERK
  • TAK-733
  • XL518 (GDC0973)
  • cancer
  • extracellular signal-regulated kinase
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1354-3776

Digital Object Identifier (DOI)

  • 10.1517/13543776.2011.577068

PubMed ID

  • 21548849
scroll to property group menus

Additional Document Info

start page

  • 1045

end page

  • 1069

volume

  • 21

issue

  • 7

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support